Novartis could produce 14 or more new big-selling 'blockbuster' drugs within five years as it bets on cancer, heart and respiratory treatments to fill the gaps left by expiries on current patents, the firm said on Thursday
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment